Page 42 - TD-2-2
P. 42

Tumor Discovery                                                       A comprehensive review of bexarotene



            68.  Jinhui ZN, 2013, CN103181912A, Bexarotene Soft Capsules   72.  Yang L, 2020, CN111718257A, Bexarotene and Ligustrazine
               and Preparation Method Thereof.                    Eutectic Compound, Preparation Method, Composition
                                                                  and Application Thereof.
            69.  Willers C, 2013, EP2612665A1, Topical Pharmaceutical
               Compositions Comprising Bexarotene and a Corticosteroide.  73.  Wei L, 2005, CN1205166C, Synthesis of Antitumour
                                                                  Medicine Bexarotene.
            70.  Lijiang C, 2018, CN104922062A, Bexarotene Nano
               Suspension.                                     74.  Bhirud  SB,  2011,  WO2011141928A1,  Process  for  the
                                                                  Preparation of Highly Pure Bexarotene.
            71.  Liu B, 2019, US20190038566A1, Bexarotene Soft Gel
               Capsule and Preparation Method Thereof.         75.  Wagner CE, 2015, US9174917B2, Bexarotene Analogs.




































































            Volume 2 Issue 2 (2023)                         16                         https://doi.org/10.36922/td.0436
   37   38   39   40   41   42   43   44   45   46   47